Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. Daniel Pollyea

Leukemia · CU Anschutz Medical Campus

View

Dr. Jessica Altman

Leukemia · Northwestern Medicine

View

Dr. Shella Saint Fleur-Lominy

Leukemia · UMSOM

View

Dr. Azra Raza

Leukemia · CUIMC

View

Dr. Molly Imgruet

Leukemia · Stanford

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    HSDr. Hossein Sadrzadeh

    Dr. Hossein Sadrzadeh

    Hematology & Oncology · Leukemia
    Beth Israel Lahey Health
    hossein

    Research

    Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma

    2025

    Via Blood

    Research

    Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy

    2024

    Via Transplantation and Cellular Therapy

    Research

    Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity

    2023

    Via Blood

    Research

    Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement

    2023

    Via British Journal of Haematology

    Research

    A woman presenting with facial droop

    2022

    Via Journal of the American College of Emergency Physicians Open

    Research

    5-Fluorouracil associated neurovascular toxicities

    2021

    Via Current Problems in Cancer

    Research

    Myelodysplastic syndrome presenting as thrombotic microangiopathy

    2020

    Via Blood

    Research

    Clustered incidence of adult acute promyelocytic leukemia.

    2018

    Via Leukemia Research

    Research

    Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia.

    2018

    Via Cancer

    Research

    Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia

    2016

    Via Haematologica

    Research

    Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues

    2014

    Via Leukemia

    Research

    Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate

    2014

    Via The Oncologist

    Research

    Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysis

    2014

    Via Leukemia Research

    Research

    Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis

    2014

    Via Leukemia & Lymphoma

    Research

    Extensive Squamous Cell Carcinoma of the Skin Related to Use of Sorafenib for Treatment of FLT3-Mutant Acute Myeloid Leukemia

    2014

    Via Journal of Clinical Oncology